rfhg_114531.1

Basic information about the TSS

---

TSS ID: rfhg_114531.1 TSS ID(Version3): hg_100491.1 hg_100492.1 hg_100490.1 Species: human Chr: chr9		Start: 34126627 End: 34126745 Strand: -
Source datasets	FANTOM5|PRJNA548673|PRJNA401781|PRJNA615891|PRJNA4843412 |DRA013844|PRJDB5282
Protocol	CAGE|ReCappable-seq|RAMPAGE|oligo_capping|SLIC_CAGE|NETCAGE |TIF-seq2|C1CAGE
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4186696,EH38E2690938)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Transcript_name: ENST00000361264.9 BC063823 AB067479 DQ518909 Distance: 0 GeneID: 25853 HGNC/MGI_ID: HGNC:19911 UniProt_ID: Q5T6F0

Gene_name: DCAF12 Gene_symbol: DCAF12 Gene_synonyms: CT102 DKFZP434O125 MGC1058 TCC52 Gene_source: HGNC:19911

TATA-Box annotation

---

Distance to TSS:	12
Nearest PromoterID:	NM_015397
Entrez ID:	25853
Nearest Unigene:	Hs.493750
Nearest Refseq:	NM_015397
Nearest Ensembl:	ENSG00000198876
Gene Name:	DCAF12
Gene Alias:	CT102|KIAA1892|TCC52|WDR40A
Gene Description:	DDB1 and CUL4 associated factor 12
Gene Type:	protein-coding
CpG%:	0.101695
GC%:	0.655462
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DCAF12 p2@DCAF12 p3@DCAF12 p4@DCAF12
Sample		p1@DCAF12	p2@DCAF12	p3@DCAF12	p4@DCAF12
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.29	5.84	1.75	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.20	8.90	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.57	11.19	0.77	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	42.62	8.11	1.46	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	41.17	8.10	1.80	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.02	9.50	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	46.41	11.33	1.53	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	41.18	9.20	2.42	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	42.96	8.33	2.35	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.92	9.85	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.15	7.68	2.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	27.24	9.35	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.33	12.57	2.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.07	8.12	1.65	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.98	11.86	2.63	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.69	11.07	2.77	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.13	11.14	1.97	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	8.44	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.46	9.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.47	10.08	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.38	7.62	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.02	6.90	0.69	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.72	7.37	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	25.48	11.16	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	23.48	13.42	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	21.21	9.50	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	9.89	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	25.46	9.67	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.41	5.98	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.87	11.40	1.45	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.35	9.00	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	28.72	10.94	1.56	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.00	8.44	0.84	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	18.64	6.10	1.81	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	34.97	10.28	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.08	12.07	1.92	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	36.58	11.85	2.66	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	29.82	11.08	2.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.76	8.91	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.81	12.00	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.47	10.12	2.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.69	9.95	1.61	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	41.55	14.76	2.32	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.84	11.89	2.10	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	40.96	12.25	2.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.59	13.73	2.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.46	17.27	2.16	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.55	10.73	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	34.95	11.01	2.63	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.04	14.96	3.44	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	37.10	10.25	2.46	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.36	14.23	3.78	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	46.84	14.55	4.26	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	45.40	13.26	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	7.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	6.43	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	57.69	20.42	2.92	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	65.84	25.37	3.85	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.26	8.80	3.46	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	55.70	26.79	4.23	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.67	22.99	2.80	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	26.27	11.94	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.88	8.83	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	74.41	22.42	4.22	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	55.38	25.91	2.13	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.64	17.06	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	36.20	18.35	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	40.81	11.73	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.43	9.94	3.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	56.30	20.11	0.93	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	49.22	20.18	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	25.50	14.41	2.53	0.79
Adipocyte - breast, donor2	11327-117E4	20.05	4.81	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	44.02	16.41	1.27	1.53
Adipocyte - omental, donor2	11474-119C7	27.66	7.47	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	32.15	12.73	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	21.69	5.74	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	7.23	4.52	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	5.39	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	23.27	7.24	1.96	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	18.27	7.72	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	10.87	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	10.58	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.93	8.77	1.37	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	12.91	7.42	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	5.87	2.67	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	18.36	7.23	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	19.13	6.65	2.08	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	17.08	7.03	1.26	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	30.76	9.82	1.64	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	10.05	3.65	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	21.66	5.08	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	16.85	7.89	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	31.66	8.82	2.16	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	8.37	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	17.67	6.57	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	7.78	6.87	0.46	0.57
Anulus Pulposus Cell, donor2	11463-119B5	7.35	4.41	0.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.59	2.70	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.08	2.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.77	2.09	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	1.98	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.47	1.95	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	2.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	4.16	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	1.13	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.41	2.47	0.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	4.09	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.10	2.71	0.90	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.37	2.46	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.16	2.14	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	2.93	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.97	1.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.89	2.40	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	1.14	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	2.28	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.92	1.92	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.39	3.61	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	1.88	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.43	2.25	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	5.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	3.01	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	2.03	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	1.78	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	5.08	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.45	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.56	2.33	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	1.53	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.57	3.86	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.83	3.61	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.44	2.07	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.17	2.80	2.29	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.35	1.65	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	3.98	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	1.43	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.31	3.10	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.75	3.88	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.62	3.18	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.99	1.82	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	25.05	9.95	2.09	0.61
Astrocyte - cerebellum, donor2	11580-120F5	21.05	8.39	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	16.78	4.82	0.84	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	21.61	10.81	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	25.07	9.54	1.62	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	30.13	9.70	1.34	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	31.19	18.69	1.15	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.45	21.67	1.63	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.16	20.48	1.59	1.59
Basophils, donor1	12241-129G9	6.28	8.63	0.26	0.52
Basophils, donor2	12242-129H1	6.49	9.38	0.36	0.36
Basophils, donor3	12243-129H2	4.26	8.23	0.15	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	17.90	4.10	1.08	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	11.89	1.37	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	26.99	5.65	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	30.78	10.61	1.04	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	27.87	11.51	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	16.91	3.42	2.16	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	77.29	49.26	2.68	3.40
Burkitt's lymphoma cell line:RAJI	10476-106I8	85.01	37.50	3.73	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.45	22.70	1.28	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.69	6.20	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	2.41	4.08	0.00	0.74
CD14+ Monocytes, donor3	11381-118B4	3.51	5.93	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.17	53.50	0.57	9.62
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.95	47.76	1.90	6.44
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.27	60.16	0.66	6.25
CD14+ monocytes - mock treated, donor1	11863-125A9	26.89	39.32	0.72	4.63
CD14+ monocytes - mock treated, donor2	11873-125C1	18.10	19.31	0.30	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	27.95	29.85	1.66	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.73	16.91	0.67	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.56	11.04	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.94	8.68	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.19	21.93	0.20	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.71	20.83	0.18	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.88	10.45	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.13	5.38	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	5.28	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	2.22	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.49	21.57	0.59	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.78	11.77	1.60	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.66	5.83	0.42	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.50	14.41	0.00	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	11.31	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	7.42	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.85	46.80	0.81	3.77
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.08	29.31	0.87	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	28.19	26.09	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.98	8.82	0.00	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	8.81	6.34	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.77	7.46	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.57	17.96	0.70	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.27	11.15	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.48	12.50	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.78	10.24	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.33	6.26	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.18	3.94	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	7.85	22.45	0.22	1.96
CD14+CD16+ Monocytes, donor2	11801-124D1	8.08	25.18	0.46	4.62
CD14+CD16+ Monocytes, donor3	11912-125G4	6.07	14.30	0.22	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	15.11	36.28	0.31	6.70
CD14+CD16- Monocytes, donor2	11799-124C8	11.00	25.50	0.17	2.79
CD14+CD16- Monocytes, donor3	11910-125G2	17.84	36.79	0.22	5.35
CD14-CD16+ Monocytes, donor1	11790-124B8	7.66	22.20	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	7.47	26.35	0.44	2.42
CD14-CD16+ Monocytes, donor3	11911-125G3	8.21	18.74	0.00	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.78	4.75	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	2.07	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3.73	2.13	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.07	2.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	1.40	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	2.35	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	2.64	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	1.01	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	685.69	44.85	25.86	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	601.23	38.75	18.78	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	7.30	5.06	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.10	22.92	2.25	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.39	23.22	2.93	3.61
CD4+ T Cells, donor1	11225-116C1	9.28	2.86	0.36	0.71
CD4+ T Cells, donor2	11306-117C1	11.63	3.67	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	6.71	6.40	0.91	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	44.16	16.34	3.32	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	51.88	19.09	1.80	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	54.62	29.03	3.74	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	20.86	10.43	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	10.53	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	42.78	20.81	2.60	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	57.62	29.32	3.05	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	54.65	24.83	1.93	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.04	14.35	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	32.84	16.07	1.05	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	27.72	9.24	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	34.15	14.76	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	55.68	29.09	2.29	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	62.82	28.73	1.34	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	26.38	16.32	1.90	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	18.22	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	14.35	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	43.58	21.14	2.41	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	48.52	29.89	2.38	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	60.10	33.83	4.41	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.74	9.10	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.10	9.96	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	18.30	7.84	2.18	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	33.65	19.30	1.98	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	32.31	14.77	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	13.96	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	32.95	23.54	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.56	26.99	2.70	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	27.72	24.64	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.39	23.99	1.07	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	18.00	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	14.73	6.88	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	9.76	4.13	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	13.38	3.79	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.43	3.21	1.61	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.61	2.40	1.44	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.97	5.75	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.42	3.90	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.52	3.12	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.01	4.55	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	20.42	4.13	1.30	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.06	3.95	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.28	3.28	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.06	4.53	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.66	4.07	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.31	3.20	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.01	4.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.41	3.19	1.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.82	4.48	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.81	2.88	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.13	1.73	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.45	4.01	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.53	5.07	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.38	4.92	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.99	2.56	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.89	4.21	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.37	2.36	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.18	3.03	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	4.82	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	2.80	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	26.05	5.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	49.35	25.59	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.82	7.41	0.49	1.48
Cardiac Myocyte, donor3	11686-122I3	13.58	5.05	0.84	0.74
Chondrocyte - de diff, donor1	11261-116G1	15.95	7.28	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	13.86	3.91	2.13	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.31	3.30	1.14	0.00
Chondrocyte - re diff, donor2	11339-117F7	54.61	17.91	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	23.05	8.90	2.02	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	21.35	12.39	1.15	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	16.03	5.34	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	17.61	4.07	1.33	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.98	23.48	2.02	1.10
Corneal Epithelial Cells, donor1	11526-119I5	14.71	5.27	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	3.41	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.98	6.39	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	3.63	11.72	0.17	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.89	7.25	0.32	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.38	7.13	0.32	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.44	16.06	0.00	3.76
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.96	20.24	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.42	23.71	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	10.01	7.50	1.00	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	4.11	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	5.37	1.13	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	16.51	9.83	2.36	1.97
Endothelial Cells - Artery, donor1	11264-116G4	8.73	4.65	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	10.12	6.35	0.94	0.71
Endothelial Cells - Artery, donor3	11413-118E9	16.65	7.36	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.31	6.21	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	3.96	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	8.46	4.51	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	6.83	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	4.17	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	6.24	4.54	0.43	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	8.00	9.60	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	3.14	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	11.93	12.80	0.75	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	7.60	6.74	0.65	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	7.94	6.96	0.73	0.73
Endothelial Cells - Vein, donor1	11267-116G7	9.10	6.83	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	9.78	4.89	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	15.86	8.95	0.79	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	3.30	3.30	1.65
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	17.59	5.62	1.22	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	8.32	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.17	4.52	4.52	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.80	1.86	0.55	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.54	7.04	0.98	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.55	4.37	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.51	3.00	0.96	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.65	2.64	0.84	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.01	2.63	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.62	4.65	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	18.60	6.35	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	3.79	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.25	1.26	0.95	0.00
Fibroblast - Cardiac, donor4	11452-119A3	20.01	10.91	1.21	0.61
Fibroblast - Cardiac, donor5	11456-119A7	13.96	8.76	0.63	0.13
Fibroblast - Cardiac, donor6	11460-119B2	13.95	6.67	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.78	8.84	1.61	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.69	5.61	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	8.79	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	20.76	9.92	0.46	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	11.36	8.48	0.51	0.34
Fibroblast - Dermal, donor1	11269-116G9	6.10	2.11	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	14.15	6.13	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.65	2.66	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	12.89	6.56	0.45	0.11
Fibroblast - Dermal, donor5	11454-119A5	15.18	5.76	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	13.48	5.85	0.81	0.16
Fibroblast - Gingival, donor1	11237-116D4	11.66	3.75	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	31.70	7.60	1.31	0.79
Fibroblast - Gingival, donor2	11318-117D4	12.26	5.14	0.79	0.66
Fibroblast - Gingival, donor3	11394-118C8	10.83	4.54	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.39	4.58	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	30.09	11.85	1.71	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.02	7.57	1.35	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	73.75	21.88	5.65	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.00	11.85	1.61	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	33.95	10.23	1.23	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.41	12.83	1.43	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.36	8.22	1.47	0.59
Fibroblast - Lung, donor1	11270-116H1	8.16	5.44	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.29	3.38	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	23.32	11.66	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	8.39	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	8.68	2.52	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	21.52	8.53	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	11.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.03	6.40	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.86	5.61	0.76	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.69	5.81	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	28.24	6.11	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.17	4.59	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	21.92	6.73	2.09	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.72	4.86	0.88	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.96	4.47	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.68	4.68	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	4.74	2.37	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.10	4.37	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.19	1.60	1.07	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.39	3.15	1.18	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.74	6.02	1.20	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.33	3.89	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.39	3.29	1.27	0.25
Fibroblast - skin normal, donor1	11553-120C5	14.11	1.80	1.64	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.66	4.21	3.01	0.60
Fibroblast - skin normal, donor2	11561-120D4	9.95	4.12	1.11	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.13	7.25	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.00	3.07	0.83	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.31	5.13	1.03	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.78	2.30	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.34	4.69	1.28	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	14.51	3.71	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.31	2.35	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	35.73	15.69	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.96	6.07	2.08	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	27.33	10.67	2.08	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	43.95	9.45	3.32	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	14.55	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.92	12.12	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.81	9.41	2.28	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.85	14.89	3.58	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	70.32	25.34	3.42	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	50.72	18.03	4.16	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	41.76	18.77	3.44	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	80.88	30.98	4.89	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.44	7.52	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.49	5.37	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.27	8.74	1.11	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.42	5.37	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.89	10.65	1.36	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.18	10.11	0.97	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.04	5.49	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.59	11.64	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.07	6.85	1.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.49	6.12	1.31	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.46	12.41	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.02	10.33	1.59	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.87	6.70	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.00	8.27	1.21	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.35	11.20	2.04	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	33.34	14.19	1.86	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.98	17.38	1.35	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.57	14.52	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.44	9.63	1.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.03	11.90	0.92	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.04	11.43	0.82	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	25.99	10.52	0.83	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	30.32	10.38	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.01	10.01	0.83	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.37	10.36	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.55	10.82	1.60	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.61	9.24	1.30	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.37	12.51	1.60	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.72	8.34	0.95	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.93	9.81	0.47	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.50	10.34	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.71	8.57	1.57	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.54	8.34	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.44	8.98	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.31	8.70	1.39	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.92	6.69	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.90	7.80	1.07	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.49	5.83	0.91	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.37	7.32	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.14	5.90	1.29	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.30	7.46	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	13.88	10.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.59	5.94	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.14	5.65	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.38	17.54	1.02	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	21.70	5.18	1.59	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.42	5.24	1.69	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.23	4.30	1.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.67	11.89	1.56	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	28.82	7.91	1.98	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.99	8.76	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	12.37	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	32.49	7.35	1.93	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	8.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.09	8.46	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	29.65	6.18	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	13.33	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.85	9.23	3.08	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	24.84	7.19	1.31	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	10.07	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.63	8.59	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.15	7.81	2.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.64	9.16	1.72	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.97	9.47	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	10.16	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	22.78	14.50	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	24.16	9.21	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.06	9.99	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	23.47	7.82	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.07	7.36	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.97	8.86	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.44	17.46	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	14.91	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.67	11.32	3.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	9.05	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.13	12.21	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.52	13.16	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	27.13	10.85	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	50.76	16.53	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.59	11.67	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.99	15.80	3.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	10.17	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.04	10.74	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	22.81	10.68	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	5.71	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	2.91	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	4.50	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.93	2.85	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	1.25	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.89	3.48	1.86	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.97	1.86	2.36	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.20	2.73	1.59	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.78	3.39	0.98	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.50	2.58	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.36	4.09	1.08	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.81	4.98	1.87	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.87	2.57	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.10	1.28	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	8.95	2.80	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.98	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	7.93	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.11	8.82	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.98	6.54	1.45	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.01	3.50	0.35	0.35
Hepatocyte, donor1	11523-119I2	14.53	4.84	1.21	0.00
Hepatocyte, donor2	11603-120I1	28.01	6.46	2.15	1.08
Hepatocyte, donor3	11684-122I1	25.16	5.52	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.04	29.37	2.61	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.52	5.24	1.40	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.15	1.78	1.23	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	37.38	4.15	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	30.03	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	43.86	11.37	4.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	5.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	42.35	7.94	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.16	6.93	3.78	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	3.09	6.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	34.89	10.98	1.29	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	40.25	9.66	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	55.41	9.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	42.82	3.78	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.02	8.84	4.82	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	2.77	2.77	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	37.76	5.66	2.36	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	26.30	9.07	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	6.46	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	44.47	8.89	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	32.86	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.28	10.20	3.19	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	5.47	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	42.13	9.28	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	30.25	6.48	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	12.29	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	47.15	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	50.07	6.95	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	4.43	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	12.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	43.60	3.49	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	6.75	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	11.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	38.79	11.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	49.70	9.20	3.68	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	6.34	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.83	5.47	0.98	0.16
Keratinocyte - epidermal, donor2	11349-117G8	17.57	5.27	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	15.62	5.58	1.33	0.28
Keratinocyte - oral, donor1	11251-116E9	21.68	8.51	0.91	0.45
Keratocytes, donor1	11527-119I6	22.35	6.53	0.69	0.00
Keratocytes, donor2	11607-120I5	11.72	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	11.86	6.13	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.84	7.04	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	15.84	1.92	1.01	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.67	8.42	1.07	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	6.42	0.00	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.33	7.24	0.79	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	5.38	1.61	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.82	10.40	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.09	6.58	0.32	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	4.92	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.07	6.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.87	5.49	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	3.96	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.56	6.20	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	5.74	0.19	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.32	6.62	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.63	7.39	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.28	5.22	0.41	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.78	4.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	3.74	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.52	6.04	0.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	3.95	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	5.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.46	5.48	0.25	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	3.39	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.27	4.58	0.54	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	5.75	0.15	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	3.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.03	3.77	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.67	5.56	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	4.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.28	4.89	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.26	5.30	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	6.30	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	5.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.05	3.72	0.50	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.00	7.03	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.93	3.71	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.05	6.19	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	5.15	0.32	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.65	5.78	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.26	5.46	0.70	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	3.91	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	5.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.34	4.67	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.88	5.73	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	6.86	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	6.59	0.24	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.51	7.30	0.25	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.66	5.12	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.53	5.97	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	4.53	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.85	6.90	4.60	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	2.97	5.20	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	23.70	10.58	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	2.81	2.11	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	2.80	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.06	3.61	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	27.36	5.95	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.04	6.79	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.23	5.53	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	4.05	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.28	9.48	2.30	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.03	8.73	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.41	4.94	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	6.66	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.56	8.15	4.58	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	7.74	2.93	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.59	5.67	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	7.36	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	7.34	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.78	4.58	1.46	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.19	7.57	2.24	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	27.82	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	23.22	4.64	2.32	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.63	5.38	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	8.30	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.98	4.24	1.77	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.91	7.38	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	4.61	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.79	4.99	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	5.66	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.15	4.92	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	19.88	4.07	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	6.46	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	3.73	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.67	5.20	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	23.26	5.60	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	8.56	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.32	4.66	3.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.15	7.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	23.46	7.11	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.94	5.16	2.75	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	4.83	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	2.02	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	4.07	6.30	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	4.65	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	6.35	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.01	6.40	2.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	30.53	10.18	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.13	6.90	4.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	1.97	4.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	21.64	5.65	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.62	6.03	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	6.31	1.80	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	10.33	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.14	5.34	3.12	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	5.47	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	27.71	5.28	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.98	3.63	3.11	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	4.38	1.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	7.27	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.55	3.09	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	20.44	5.40	3.47	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	6.08	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.03	3.84	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.08	5.96	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.30	4.25	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	6.23	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.46	7.22	3.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.04	6.20	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	8.47	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.87	5.39	1.58	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	8.53	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	26.43	4.02	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	4.11	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.76	7.07	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	5.11	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.71	3.74	2.50	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	4.70	3.13	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.04	4.59	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.12	5.11	1.39	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.75	5.35	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.71	6.95	2.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	4.85	1.21	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	1.84	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	9.78	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	19.38	7.41	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	3.07	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	3.28	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	23.16	5.79	2.67	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.58	6.24	1.56	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	9.28	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.74	29.40	0.68	3.65
Macrophage - monocyte derived, donor2	11313-117C8	17.98	19.27	0.18	2.20
Macrophage - monocyte derived, donor3	11389-118C3	16.52	21.50	0.92	3.28
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	14.89	4.44	2.06	0.00
Mallassez-derived cells, donor3	11930-125I4	16.40	3.89	0.83	0.00
Mammary Epithelial Cell, donor1	11273-116H4	21.32	11.56	1.89	0.50
Mammary Epithelial Cell, donor2	11350-117G9	21.43	6.37	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	15.96	4.74	2.00	0.50
Mast cell - stimulated, donor1	11487-119E2	8.81	4.75	0.00	2.71
Mast cell, donor1	11563-120D6	29.63	23.79	1.73	3.35
Mast cell, donor2	11565-120D8	22.59	35.07	0.59	3.57
Mast cell, donor3	11566-120D9	27.47	31.74	0.23	3.60
Mast cell, donor4	11567-120E1	28.72	41.13	0.71	5.14
Mast cell, expanded and stimulated, donor5	11940-126A5	27.39	18.96	1.00	2.44
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	30.94	0.58	5.84
Mast cell, expanded, donor5	11939-126A4	31.20	23.98	1.72	3.44
Mast cell, expanded, donor8	11941-126A6	35.65	24.60	1.84	4.02
Melanocyte - dark, donor1	11502-119F8	10.65	6.27	0.40	1.09
Melanocyte - dark, donor2	11582-120F7	15.57	5.88	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	17.31	11.45	0.87	0.87
Melanocyte - light, donor1	11274-116H5	14.10	6.58	0.24	0.47
Melanocyte - light, donor2	11351-117H1	15.70	7.51	0.68	0.00
Melanocyte - light, donor3	11423-118G1	12.14	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.22	9.89	1.56	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	23.13	9.14	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	19.02	5.09	0.80	0.27
Meningeal Cells, donor1	11493-119E8	27.67	13.15	0.74	0.25
Meningeal Cells, donor2	11573-120E7	20.69	7.92	0.00	0.88
Meningeal Cells, donor3	11654-122E7	16.63	11.00	0.57	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.98	5.99	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.22	4.13	1.21	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	6.46	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.86	2.96	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.61	6.03	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.65	5.05	1.32	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.92	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.05	3.68	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7.20	2.63	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.38	9.29	1.49	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.26	6.84	0.53	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.50	2.97	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	4.48	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.99	6.03	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.76	3.44	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	2.90	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	24.66	5.30	2.92	0.27
Mesothelial Cells, donor2	12156-128G5	18.02	1.50	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	25.15	4.84	1.88	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	16.20	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.12	35.96	0.99	2.71
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	29.74	27.09	0.88	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.22	18.29	0.31	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.18	22.20	0.41	2.07
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	4.63	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	31.78	34.54	2.25	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.74	21.41	0.47	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	20.93	27.23	0.61	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	25.34	0.79	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	7.96	0.00	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	19.00	0.38	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.22	16.55	0.00	1.91
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	8.29	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	22.35	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	6.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	21.08	0.25	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	11.17	15.45	0.48	3.33
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	1.66	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.04	11.74	0.00	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.19	20.82	0.42	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.23	17.12	0.20	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.66	16.95	0.43	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.67	14.67	0.44	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.07	11.39	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	15.72	0.00	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.61	14.13	0.00	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	20.00	0.59	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	11.53	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.61	36.82	2.40	3.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.01	9.01	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.52	14.45	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	9.93	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	3.84	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	15.62	0.50	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	9.05	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	13.33	0.68	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.75	11.38	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	5.68	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.96	8.70	0.84	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.13	7.90	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	9.32	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.59	13.27	0.60	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	24.21	18.37	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	14.78	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.61	21.63	2.28	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.09	13.40	1.52	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.73	10.37	0.52	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.45	14.59	0.43	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	4.45	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.28	10.14	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.51	29.93	1.50	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.00	11.02	1.13	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.56	16.88	1.27	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.01	19.90	0.44	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.10	10.62	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	14.77	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.33	20.65	1.47	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	5.87	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.94	17.35	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.00	25.37	3.17	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.21	38.74	0.41	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	16.38	0.30	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	11.30	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	16.04	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.86	35.16	0.66	4.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	21.04	0.00	6.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	38.35	59.11	0.99	5.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	40.98	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.03	42.06	1.50	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	24.77	26.90	1.07	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.14	18.32	0.79	1.92
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	26.52	0.00	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	31.15	39.94	0.00	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	29.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	12.29	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	15.46	7.73	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	21.21	0.00	6.06
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	27.83	0.42	3.37
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	9.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	5.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	21.15	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	45.68	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	62.75	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.77	2.59	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	2.09	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	5.34	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	3.76	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.93	4.18	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3.19	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	5.44	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.23	8.79	0.84	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.88	7.21	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	15.67	6.22	1.89	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.07	7.36	1.68	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	3.47	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	4.06	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.05	4.31	2.04	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.64	6.86	2.12	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.12	1.64	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.91	6.37	3.18	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	4.80	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.56	4.59	1.64	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.20	3.42	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.70	2.82	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	8.44	1.41	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.07	7.82	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	9.64	1.61	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.00	2.07	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.03	3.12	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	6.77	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.33	7.36	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.46	10.73	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.33	5.66	3.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	2.71	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	5.95	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	7.43	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	7.19	2.27	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.55	5.87	2.61	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.61	9.59	2.18	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	3.17	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	30.87	6.17	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	5.98	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.83	5.95	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	3.06	1.53	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.61	3.93	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.94	2.21	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.04	6.78	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	7.93	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.83	6.29	3.15	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.04	7.57	1.82	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	2.37	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.81	2.98	0.37	0.12
Myoblast, donor2	11322-117D8	11.70	3.07	1.15	0.00
Myoblast, donor3	11398-118D3	9.42	5.55	1.01	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	24.08	8.03	1.02	0.15
Natural Killer Cells, donor1	11230-116C6	12.92	5.23	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	17.19	4.22	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	12.33	4.42	0.55	0.74
Neural stem cells, donor1	11275-116H6	74.40	39.20	3.27	1.09
Neural stem cells, donor2	11352-117H2	44.29	19.26	1.93	0.00
Neurons, donor1	11494-119E9	22.76	13.65	0.00	0.00
Neurons, donor2	11574-120E8	27.52	12.77	0.88	0.88
Neurons, donor3	11655-122E8	28.78	12.33	0.82	3.29
Neutrophils, donor1	11233-116C9	28.77	21.34	0.93	0.93
Neutrophils, donor2	11314-117C9	72.47	26.09	0.00	0.00
Neutrophils, donor3	11390-118C4	67.80	50.70	1.83	5.50
Nucleus Pulposus Cell, donor1	11252-116F1	10.92	6.65	0.71	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	7.49	5.86	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	11.63	5.01	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	16.79	4.82	1.24	0.69
Olfactory epithelial cells, donor2	11934-125I8	13.90	3.47	0.72	0.58
Olfactory epithelial cells, donor3	11935-125I9	15.21	3.75	1.59	0.34
Olfactory epithelial cells, donor4	11936-126A1	18.80	6.04	1.27	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	18.05	6.02	3.01	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.97	4.47	1.06	0.43
Osteoblast - differentiated, donor2	11353-117H3	10.29	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	19.93	6.45	1.95	0.00
Osteoblast, donor2	11354-117H4	9.13	3.51	2.11	1.40
Osteoblast, donor3	11426-118G4	19.37	5.51	1.60	0.36
Pancreatic stromal cells, donor1	11249-116E7	9.43	3.20	0.34	0.17
Pericytes, donor1	11491-119E6	12.80	6.45	0.45	0.45
Pericytes, donor2	11571-120E5	15.62	9.05	0.45	0.68
Pericytes, donor3	11652-122E5	9.77	4.48	0.81	0.00
Perineurial Cells, donor1	11499-119F5	13.00	4.63	0.68	0.00
Perineurial Cells, donor2	11579-120F4	18.59	8.65	0.74	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.53	9.88	0.32	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	17.87	9.79	0.00	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	12.04	8.02	0.52	0.78
Placental Epithelial Cells, donor1	11278-116H9	24.63	3.59	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	23.29	6.65	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.58	5.69	0.98	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.77	4.11	1.58	0.63
Preadipocyte - breast, donor1	11467-119B9	27.76	7.69	0.94	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.84	3.39	1.83	0.13
Preadipocyte - breast, donor2	11328-117E5	18.69	4.95	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	40.17	10.44	2.56	0.75
Preadipocyte - omental, donor2	11329-117E6	43.21	8.29	3.06	0.00
Preadipocyte - omental, donor3	11403-118D8	24.93	5.16	2.01	0.43
Preadipocyte - perirenal, donor1	11469-119C2	13.78	5.91	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	15.36	3.99	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	17.35	4.07	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	8.68	4.43	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.69	4.75	0.93	0.75
Preadipocyte - visceral, donor2	11357-117H7	8.28	2.76	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	11.08	4.28	0.73	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.59	4.07	1.36	0.15
Prostate Epithelial Cells, donor2	11331-117E8	15.17	2.57	0.95	0.41
Prostate Epithelial Cells, donor3	11404-118D9	18.62	3.86	1.29	0.18
Prostate Stromal Cells, donor1	11254-116F3	11.62	3.30	0.46	0.46
Prostate Stromal Cells, donor2	11332-117E9	15.78	4.48	0.54	0.54
Prostate Stromal Cells, donor3	11405-118E1	9.91	2.09	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.99	10.58	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	19.06	6.58	0.49	0.21
Renal Epithelial Cells, donor1	11517-119H5	17.25	5.58	1.52	0.51
Renal Epithelial Cells, donor2	11597-120H4	22.05	12.09	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	26.78	7.20	1.38	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	4.77	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.50	9.03	0.81	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.54	3.77	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	2.66	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.37	7.92	1.10	0.66
Renal Mesangial Cells, donor2	11598-120H5	30.72	8.78	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	12.76	7.77	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.96	5.37	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.98	6.75	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.25	5.98	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.22	5.19	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	23.02	7.11	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.32	6.52	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.74	12.03	0.67	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	30.38	3.57	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	41.83	11.01	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.64	3.48	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	19.50	4.81	1.56	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.75	5.66	1.99	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.00	6.47	1.56	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	23.20	5.58	2.60	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.21	5.83	1.75	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.89	5.08	2.08	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.71	4.24	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.14	6.35	2.12	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	28.13	5.55	1.97	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	19.94	5.74	0.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.61	5.26	1.82	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.90	3.54	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	21.03	2.68	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.01	3.63	1.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.88	4.51	2.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.70	3.72	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.13	4.77	1.56	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	20.62	6.11	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.65	3.74	0.85	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.10	3.36	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.58	3.76	1.54	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.79	2.92	1.82	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.11	4.29	0.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.91	4.03	1.61	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.96	7.08	1.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.60	5.36	1.59	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.68	4.68	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.30	3.73	3.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.90	5.53	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.76	4.18	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.40	5.25	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.54	3.92	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.56	6.94	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.79	4.64	2.06	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.65	5.49	1.51	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.48	5.42	1.97	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.52	3.58	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.61	4.29	1.48	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.86	4.00	1.07	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.37	6.22	1.52	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.86	7.86	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.01	5.64	1.61	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.05	6.97	1.51	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.20	10.83	2.79	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.67	6.04	1.51	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.03	8.32	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	34.20	11.94	2.62	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	26.77	7.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	23.21	7.84	2.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.82	8.14	2.04	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.06	6.89	2.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	26.21	11.81	1.30	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.87	13.45	1.71	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	36.06	13.82	3.00	0.60
Schwann Cells, donor1	11498-119F4	13.16	8.09	0.94	0.00
Schwann Cells, donor2	11578-120F3	6.80	10.21	3.40	0.00
Schwann Cells, donor3	11659-122F3	7.67	5.26	0.22	0.00
Sebocyte, donor1	11220-116B5	33.96	11.50	2.19	0.55
Sebocyte, donor2	11301-117B5	42.28	11.49	1.84	0.00
Sebocyte, donor3	11378-118B1	22.26	3.71	1.44	0.00
Sertoli Cells, donor1	11255-116F4	24.85	13.25	1.66	0.00
Sertoli Cells, donor2	11333-117F1	42.37	14.12	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.88	8.36	0.70	0.62
Skeletal Muscle Cells, donor2	11358-117H8	11.57	6.51	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.10	10.87	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.81	8.01	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	16.20	7.88	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	15.70	8.00	0.77	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	9.58	9.95	0.25	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	8.99	6.56	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.06	6.55	0.79	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.70	7.92	1.52	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	10.86	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.86	7.71	1.24	0.41
Skin - palm, donor1	10286-104F7	16.12	8.06	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.85	3.17	1.73	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	66.25	5.73	4.91	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.70	7.53	0.65	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	16.54	6.12	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	16.74	4.92	1.83	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	46.94	13.11	3.81	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	17.01	5.02	1.57	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.26	1.85	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.56	1.78	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	4.11	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.17	4.20	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	3.54	1.97	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	2.32	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	5.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.38	1.86	1.06	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.42	2.88	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.67	7.17	1.66	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	5.86	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.70	2.36	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.81	2.56	0.85	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.74	2.28	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.05	2.44	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.15	6.82	1.01	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	3.34	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.85	2.51	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.75	3.44	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.60	3.15	0.52	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.54	6.50	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	3.23	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.25	5.68	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.00	3.07	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.13	4.24	0.31	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.21	4.03	1.11	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.79	3.87	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	7.25	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.31	5.83	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.65	4.53	0.67	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.53	4.51	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.62	3.04	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.66	4.67	0.60	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	9.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	3.88	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	22.79	7.91	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	5.01	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.49	1.47	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.25	4.67	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	3.27	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.66	2.59	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.45	4.59	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.47	3.38	1.50	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	10.34	2.52	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.57	2.93	0.34	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.32	3.91	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.37	3.76	1.55	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.36	4.39	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.10	2.72	0.97	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.43	2.64	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.60	3.35	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.06	3.23	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	2.27	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.39	3.15	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	13.46	3.56	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	3.19	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.96	0.84	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.50	4.58	0.46	0.00
Synoviocyte, donor1	11291-117A4	9.93	4.21	0.34	0.17
Synoviocyte, donor2	11368-117I9	7.88	2.68	0.34	0.67
Synoviocyte, donor3	11440-118H9	12.29	3.35	1.12	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	18.58	7.86	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.49	5.56	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	28.32	10.32	1.43	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	13.53	3.48	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	27.49	13.74	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	35.43	11.56	1.60	0.98
Urethra, donor2	10319-105A4	44.96	12.59	0.00	1.80
Urothelial Cells, donor1	11520-119H8	21.78	2.39	1.06	0.00
Urothelial Cells, donor2	11600-120H7	17.22	4.01	2.40	0.40
Urothelial Cells, donor3	11681-122H7	19.25	4.35	1.38	0.23
Urothelial cells, donor0	11216-116B1	18.95	6.69	1.56	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	7675.27	734.96	91.65	9.79
Whole blood (ribopure), donor090309, donation2	12180-129A2	9675.61	896.37	114.37	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	7769.30	544.19	91.73	9.58
Whole blood (ribopure), donor090325, donation1	12176-128I7	3966.43	317.82	31.33	6.54
Whole blood (ribopure), donor090325, donation2	12177-128I8	4232.79	327.12	30.21	5.23
Whole blood (ribopure), donor090612, donation1	12182-129A4	6407.79	599.75	67.68	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	7386.39	695.69	107.38	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	7372.57	546.83	99.51	10.04
Wilms' tumor cell line:G-401	10809-111A8	31.70	11.84	1.73	0.86
Wilms' tumor cell line:HFWT	10597-108E3	20.24	2.64	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.26	3.91	2.79	0.00
achilles tendon, donor2	10292-104G4	16.53	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.05	15.81	5.61	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.17	31.34	2.55	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	56.27	28.13	2.97	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	53.06	35.37	3.27	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	63.52	15.18	1.41	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	48.22	32.57	1.69	2.96
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.06	32.12	1.36	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.98	28.64	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	105.77	46.96	2.45	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	88.92	73.39	1.16	5.82
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	29.26	16.56	0.92	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	19.50	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.04	7.90	1.39	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	73.53	45.83	3.11	3.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	32.73	35.65	0.29	4.97
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	47.41	46.48	0.93	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	94.59	65.80	0.41	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	119.71	208.42	3.99	26.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	49.07	99.85	1.28	15.79
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.93	102.82	1.82	18.80
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	70.53	116.26	1.93	18.53
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.55	32.07	1.11	2.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.68	6.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	50.17	11.15	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	62.15	11.68	4.52	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.07	19.19	1.74	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	34.85	5.18	2.59	0.00
adipose tissue, adult, pool1	10010-101C1	17.53	13.03	0.47	1.86
adipose, donor1	10184-103D4	18.77	8.80	3.52	1.17
adipose, donor2	10185-103D5	57.58	19.87	1.62	0.81
adipose, donor3	10186-103D6	60.99	25.60	3.00	1.63
adipose, donor4	10187-103D7	37.27	7.80	2.60	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.63	2.84	1.74	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	25.46	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.61	13.47	1.33	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	30.37	5.72	3.93	0.00
amniotic membrane cells, donor1	12235-129G3	36.63	11.36	4.17	0.93
amniotic membrane cells, donor2	12236-129G4	31.11	10.14	4.40	0.68
amniotic membrane cells, donor3	12237-129G5	16.50	7.37	1.77	0.59
amygdala - adult, donor10196	10167-103B5	24.90	9.49	2.37	0.00
amygdala, adult, donor10252	10151-102I7	23.52	7.71	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	30.99	6.13	1.61	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	21.65	5.98	2.04	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	80.31	22.28	5.07	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	91.19	25.72	3.01	1.00
aorta, adult, pool1	10052-101G7	32.36	7.06	1.18	0.78
appendix, adult	10189-103D9	34.93	32.21	1.94	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	47.46	11.69	3.78	0.34
artery, adult	10190-103E1	17.66	10.87	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	29.55	11.01	1.45	0.43
b cell line:RPMI1788	10427-106D4	30.19	13.09	1.93	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.53	3.61	1.94	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	23.12	2.58	1.19	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	21.42	5.02	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	27.96	62.08	1.12	7.27
bladder, adult, pool1	10011-101C2	22.27	7.17	0.87	0.65
blood, adult, pool1	10053-101G8	5904.19	318.91	168.31	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	4.28	3.43	0.00
bone marrow, adult	10192-103E3	51.96	19.57	0.67	2.02
brain, adult, donor1	10084-102B3	22.55	14.35	0.00	1.03
brain, adult, pool1	10012-101C3	12.25	5.57	0.33	0.00
brain, fetal, pool1	10085-102B4	56.10	26.71	2.67	5.34
breast carcinoma cell line:MCF7	10482-107A5	21.14	7.27	2.64	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.44	12.36	4.49	1.25
breast, adult, donor1	10080-102A8	27.15	17.68	1.26	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.99	2.41	2.16	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	34.32	3.71	4.33	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.12	2.07	2.07	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	2.18	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	47.96	7.99	3.29	0.47
carcinoid cell line:NCI-H727	10735-110B6	20.45	4.05	1.42	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	25.35	6.97	1.90	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.43	11.98	1.86	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	10.36	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.55	4.35	0.50	0.50
caudate nucleus, adult, donor10258	10379-105H1	18.34	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	36.99	8.79	1.46	1.46
cerebellum - adult, donor10196	10173-103C2	37.87	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	37.79	2.78	0.43	0.43
cerebellum, adult, pool1	10083-102B2	21.73	7.24	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	63.10	7.47	1.66	0.83
cerebral meninges, adult	10188-103D8	15.13	4.79	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	46.05	3.65	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	44.72	7.19	1.58	0.58
cervical cancer cell line:ME-180	10553-107I4	45.74	14.58	1.99	0.17
cervix, adult, pool1	10013-101C4	26.46	11.44	0.52	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	19.65	6.69	1.39	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.48	11.43	1.37	0.75
choriocarcinoma cell line:SCH	10785-110H2	22.55	6.90	0.99	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	31.54	12.57	2.61	0.47
chorionic membrane cells, donor1	12238-129G6	17.67	14.53	1.14	0.28
chorionic membrane cells, donor2	12239-129G7	28.84	10.64	3.08	0.20
chorionic membrane cells, donor3	12240-129G8	16.48	17.03	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	13.13	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.79	16.14	2.11	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.17	23.23	1.06	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	31.33	5.14	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	37.49	3.39	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.51	4.28	1.22	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	123.08	20.91	3.24	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	35.18	19.55	1.30	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	17.37	5.26	1.14	0.00
clear cell carcinoma cell line:TEN	10636-108I6	21.86	2.26	0.87	0.00
colon carcinoma cell line:CACO-2	10513-107D9	16.84	3.29	1.28	0.00
colon carcinoma cell line:COLO-320	10420-106C6	59.67	13.30	7.22	1.14
colon, adult, donor1	10082-102B1	36.89	11.90	4.76	2.38
colon, adult, pool1	10014-101C5	28.44	15.28	1.18	1.18
colon, fetal, donor1	10070-101I7	62.42	24.10	4.33	1.85
common myeloid progenitor CMP, donor1	12130-128D6	32.08	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	43.77	13.17	0.85	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	31.39	8.90	1.21	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	35.68	8.88	1.27	0.28
corpus callosum, adult, pool1	10042-101F6	27.75	11.50	0.66	0.66
cruciate ligament, donor2	10295-104G7	21.88	11.35	0.00	2.43
diaphragm, fetal, donor1	10069-101I6	31.30	12.04	0.00	1.61
diencephalon, adult	10193-103E4	9.84	3.12	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.95	11.25	2.30	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	42.06	6.15	1.54	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.80	3.13	0.72	0.24
ductus deferens, adult	10196-103E7	21.43	6.98	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	20.16	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	26.48	8.83	0.00	1.47
dura mater, adult, donor1	10041-101F5	35.43	13.30	0.66	1.65
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	54.85	22.65	1.33	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	55.45	16.62	3.01	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	1.85	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.68	3.94	2.12	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.97	1.54	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	51.96	5.36	6.03	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	35.88	8.70	4.53	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.09	4.66	1.77	0.00
epidermoid carcinoma cell line:A431	10426-106D3	32.24	11.00	1.78	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	25.08	5.06	2.20	0.22
epididymis, adult	10197-103E8	25.33	14.44	0.42	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	7.45	3.37	0.18	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.17	6.69	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	47.96	9.44	2.75	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.52	10.24	1.87	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	44.48	7.95	3.14	0.00
esophagus, adult, pool1	10015-101C6	25.16	11.15	2.12	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	21.29	6.51	1.25	0.38
eye - muscle inferior rectus, donor1	10272-104E2	24.15	9.66	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	18.94	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	4.46	0.00	1.49
eye - muscle superior, donor2	10297-104G9	41.27	17.20	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	10.20	8.74	0.00	0.00
eye, fetal, donor1	10054-101G9	31.78	10.42	1.53	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	22.44	7.31	1.41	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.53	3.09	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	16.61	5.07	0.56	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	57.05	9.01	6.61	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	16.64	1.92	2.01	0.09
gall bladder, adult	10198-103E9	24.14	9.42	0.72	1.45
gamma delta positive T cells, donor1	11937-126A2	71.40	29.53	3.22	0.54
gamma delta positive T cells, donor2	11938-126A3	54.53	28.01	1.12	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	53.44	16.26	2.75	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	16.83	1.74	1.55	0.00
gastric cancer cell line:AZ521	10549-107H9	30.66	6.23	2.46	0.16
gastric cancer cell line:GSS	10560-108A2	21.05	5.49	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.87	14.39	1.83	0.46
giant cell carcinoma cell line:LU65	10487-107B1	45.55	4.59	2.64	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	21.41	5.32	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.94	4.99	2.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.55	5.38	2.96	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.05	4.92	2.11	0.14
glioblastoma cell line:T98G	10485-107A8	19.87	6.07	0.88	0.11
glioma cell line:GI-1	10413-106B8	26.07	5.86	1.46	0.00
globus pallidus - adult, donor10196	10175-103C4	18.95	8.02	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	28.07	6.83	0.73	0.49
globus pallidus, adult, donor10258	10367-105F7	9.58	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.85	4.80	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	4.89	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	20.91	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	37.44	6.72	1.92	0.00
hIPS +CCl2, biol_rep1	14383-156B9	21.12	3.67	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.46	2.74	2.74	0.00
hIPS +CCl2, biol_rep3	14385-156C2	26.41	7.73	1.93	0.00
hIPS, biol_rep1	14380-156B6	24.43	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.20	2.06	2.06	0.00
hIPS, biol_rep3	14382-156B8	12.14	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	18.10	11.78	0.86	0.86
heart - mitral valve, adult	10205-103F7	23.62	8.67	0.60	1.20
heart - pulmonic valve, adult	10206-103F8	12.81	6.54	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	33.31	9.16	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.00	5.92	1.43	0.41
heart, adult, diseased, donor1	10051-101G6	21.29	7.24	0.00	0.00
heart, adult, pool1	10016-101C7	20.01	8.51	0.69	0.46
heart, fetal, pool1	10046-101G1	85.43	14.17	2.26	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.80	1.54	1.85	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	32.26	11.38	1.55	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.56	10.44	1.70	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.54	12.53	1.62	0.51
hepatoma cell line:Li-7	10484-107A7	41.48	10.01	1.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.16	13.27	1.71	0.50
hippocampus - adult, donor10196	10169-103B7	17.98	4.73	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	25.10	5.71	1.84	0.41
hippocampus, adult, donor10258	10374-105G5	9.96	2.99	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	21.15	7.75	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	28.69	10.38	3.05	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.99	6.68	0.98	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	38.34	11.68	2.79	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	12.97	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.83	19.37	3.36	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.54	23.92	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	61.31	23.65	2.92	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	89.62	35.33	4.09	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	66.73	24.19	1.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.17	22.26	0.95	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	72.32	34.55	2.25	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	70.02	23.57	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	23.79	5.48	2.50	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.60	3.93	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	25.31	5.24	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	61.66	20.81	4.39	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.46	23.98	6.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	46.48	14.99	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	56.33	21.48	1.13	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	62.30	20.01	1.36	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	45.11	16.91	2.19	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	41.48	21.88	1.31	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.97	22.35	1.16	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.96	20.33	1.20	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.65	10.35	1.29	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.39	7.42	2.57	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.03	9.80	2.04	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	17.25	2.82	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.44	13.94	4.12	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	18.46	3.33	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	52.75	24.30	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	63.76	29.22	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	31.04	14.11	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.60	17.13	2.05	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	74.97	31.05	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.11	20.16	1.68	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.67	8.94	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.96	8.91	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	10.24	3.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.31	20.48	1.83	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	22.77	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.07	22.84	3.64	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	69.51	14.78	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.55	13.03	2.17	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.94	15.66	0.71	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	11.93	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	44.15	21.26	1.08	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	36.64	12.39	1.35	0.81
immature langerhans cells, donor1	11904-125F5	3.63	10.65	0.24	1.45
immature langerhans cells, donor2	11905-125F6	6.34	12.67	0.00	0.79
insula, adult, pool1	10039-101F3	19.12	6.25	0.47	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	36.74	9.75	2.28	0.33
kidney, adult, pool1	10017-101C8	18.22	10.21	1.00	1.00
kidney, fetal, pool1	10045-101F9	54.54	14.29	1.49	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.02	5.40	0.71	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.52	5.25	0.83	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.85	3.85	1.28	0.18
left atrium, adult, donor1	10079-102A7	17.44	13.08	0.00	2.18
left ventricle, adult, donor1	10078-102A6	12.14	8.09	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	12.31	2.46	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	8.62	3.23	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	13.59	2.17	0.00	0.00
leiomyoma cell line:15425	10571-108B4	8.98	2.67	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	7.32	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.15	9.68	1.06	0.35
liposarcoma cell line:KMLS-1	10782-110G8	7.19	1.09	0.94	0.00
liposarcoma cell line:SW 872	10726-110A6	24.37	6.34	2.56	0.37
liver, adult, pool1	10018-101C9	20.74	8.59	0.97	0.49
liver, fetal, pool1	10086-102B5	170.27	24.46	1.88	1.88
locus coeruleus - adult, donor10196	10182-103D2	17.64	5.83	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	21.59	7.38	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	20.88	9.31	0.85	1.13
locus coeruleus, newborn, donor10223	10362-105F2	28.60	8.83	0.42	2.10
lung adenocarcinoma cell line:A549	10499-107C4	27.68	7.47	1.52	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	13.79	1.38	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	56.68	10.94	2.37	0.66
lung, adult, pool1	10019-101D1	39.10	12.88	1.30	1.30
lung, fetal, donor1	10068-101I5	329.36	44.81	7.42	2.28
lung, right lower lobe, adult, donor1	10075-102A3	39.86	20.62	1.83	3.21
lymph node, adult, donor1	10077-102A5	17.04	21.30	0.00	4.73
lymphangiectasia cell line:DS-1	10727-110A7	27.18	9.64	1.32	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	96.44	41.50	5.43	2.72
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	4.25	0.00	0.00
mature adipocyte, donor1	12231-129F8	13.76	11.10	0.44	0.44
mature adipocyte, donor2	12232-129F9	21.38	7.06	0.62	0.42
mature adipocyte, donor3	12233-129G1	20.62	8.30	0.71	0.47
mature adipocyte, donor4	12234-129G2	15.00	13.42	0.79	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.07	5.48	4.53	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	2.26	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	18.21	4.97	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	10.80	2.22	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	16.21	5.12	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	14.85	5.40	0.84	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	21.01	3.61	1.06	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	31.94	8.61	1.79	1.08
medulla oblongata - adult, donor10196	10174-103C3	29.20	5.19	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	21.05	6.35	0.93	0.93
medulla oblongata, adult, pool1	10038-101F2	17.39	6.94	1.06	0.49
medulla oblongata, newborn, donor10223	10361-105F1	38.54	7.64	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	36.98	10.85	3.76	0.22
medulloblastoma cell line:ONS-76	10759-110E3	13.33	5.26	0.86	0.24
melanoma cell line:COLO 679	10514-107E1	20.12	8.91	0.43	0.57
melanoma cell line:G-361	10465-106H6	17.92	4.61	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	18.09	4.88	1.27	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	74.90	29.96	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	126.50	39.66	8.30	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.21	2.45	1.23	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.27	2.00	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	10.77	1.66	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.04	0.70	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.90	2.31	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	4.16	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.41	2.23	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.27	2.76	1.15	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.89	3.71	1.06	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.94	3.24	0.68	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.53	2.28	1.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	3.62	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.20	2.63	0.55	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.06	4.19	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.57	0.82	1.02	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.82	3.95	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.62	2.28	0.83	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.40	2.05	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	5.03	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.12	2.84	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.99	3.15	0.79	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	24.30	4.42	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.45	3.15	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.16	12.63	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	3.20	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.77	3.84	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.44	4.19	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	2.77	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.83	2.12	1.65	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.12	2.37	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	1.96	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.66	3.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.65	4.33	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.92	2.45	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.69	4.33	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	2.93	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.08	4.03	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.42	3.28	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.74	2.15	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	5.47	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.59	2.92	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.19	5.33	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	10.63	4.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.44	6.22	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	6.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	7.71	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	9.75	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	11.40	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.07	7.93	2.07	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.56	3.67	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	5.56	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	3.54	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.09	4.68	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	8.28	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	21.34	2.75	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.79	6.43	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	7.85	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	25.44	10.18	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	38.28	6.85	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	13.08	10.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	48.15	7.60	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	51.59	10.92	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	13.18	3.29	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	38.10	12.90	1.98	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.93	9.09	2.27	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	8.15	4.07	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	7.74	3.87	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	23.62	4.25	1.65	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	40.31	8.11	3.48	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.90	7.50	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	21.33	7.72	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	23.23	4.65	2.20	0.00
mesothelioma cell line:Mero-48a	10852-111F6	37.20	10.85	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	19.97	6.83	1.05	0.26
mesothelioma cell line:Mero-83	10854-111F8	29.28	8.85	2.89	0.34
mesothelioma cell line:Mero-84	10855-111F9	18.96	4.30	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	18.22	4.76	0.62	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	23.52	4.47	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	6.70	2.90	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	9.91	3.76	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	24.94	4.07	1.02	0.25
mesothelioma cell line:No36	10857-111G2	26.10	4.24	1.96	0.33
mesothelioma cell line:ONE58	10858-111G3	15.17	2.71	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	1.15	0.77	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	1.34	0.61	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	2.69	0.90	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.06	8.81	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.76	6.78	1.91	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.42	5.07	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.22	7.80	0.76	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	128.06	75.03	2.22	5.17
myeloma cell line:PCM6	10474-106I6	24.91	20.16	0.59	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	2.03	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	9.61	2.55	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.76	7.24	4.23	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	33.31	5.81	2.43	0.29
nasal epithelial cells, donor2	12227-129F4	37.54	12.14	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	36.35	18.86	1.84	1.38
neuroblastoma cell line:NB-1	10539-107G8	39.29	14.22	3.37	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	29.74	9.28	2.53	0.21
neuroblastoma cell line:NH-12	10555-107I6	40.07	9.88	2.61	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.73	14.23	0.24	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.81	12.67	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	56.55	15.09	2.82	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	40.05	8.90	2.54	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.37	2.13	0.53	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	89.30	83.38	2.54	5.92
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	45.63	8.01	4.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.80	7.37	2.24	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.08	5.26	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	18.37	5.72	1.31	0.56
occipital cortex - adult, donor10196	10172-103C1	26.78	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	24.15	3.76	1.34	1.07
occipital cortex, newborn, donor10223	10355-105E4	22.56	6.55	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	42.25	16.01	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	122.72	36.04	4.72	1.29
occipital pole, adult, pool1	10036-101E9	15.61	3.47	0.95	0.24
olfactory region, adult	10195-103E6	13.37	3.44	0.76	0.00
optic nerve, donor1	10277-104E7	62.03	20.01	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	29.73	6.38	2.73	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.43	3.43	1.37	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	33.53	6.10	1.52	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.85	3.58	1.73	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	7.64	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	12.15	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	23.54	9.12	0.42	0.00
ovary, adult, pool1	10020-101D2	23.50	11.53	1.14	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.90	1.47	0.92	0.18
pancreas, adult, donor1	10049-101G4	27.28	17.87	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.37	15.93	2.24	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	42.42	12.95	1.36	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.98	6.95	0.83	0.50
paracentral gyrus, adult, pool1	10035-101E8	16.84	5.03	0.64	0.55
parietal cortex, adult, donor10258	10373-105G4	12.48	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	20.69	4.70	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	15.68	2.00	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	15.95	5.11	1.15	0.62
parietal lobe, fetal, donor1	10072-101I9	77.59	17.46	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	32.15	8.60	0.75	0.75
parotid gland, adult	10199-103F1	17.27	13.57	1.23	0.62
penis, adult	10200-103F2	20.41	10.21	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	9.11	6.14	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.72	4.95	2.48	0.15
pineal gland - adult, donor10196	10179-103C8	15.48	3.23	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	31.39	14.81	3.55	1.18
pineal gland, adult, donor10258	10377-105G8	15.05	6.27	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	34.40	9.11	4.05	1.01
pituitary gland, adult, donor10252	10162-103A9	46.91	7.30	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	33.20	11.92	0.00	0.85
placenta, adult, pool1	10021-101D3	51.39	13.12	3.87	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	24.90	9.40	2.52	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	50.58	11.21	5.14	0.78
pons, adult, pool1	10033-101E6	11.88	4.91	0.34	0.43
postcentral gyrus, adult, pool1	10032-101E5	16.04	5.84	0.96	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	27.54	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	48.51	4.22	7.87	0.15
prostate cancer cell line:PC-3	10439-106E7	21.42	4.72	1.82	0.00
prostate, adult, pool1	10022-101D4	16.60	5.80	1.00	0.63
putamen, adult, donor10196	10176-103C5	15.58	3.78	0.24	0.94
putamen, adult, donor10252	10152-102I8	31.37	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	11.60	4.11	0.48	0.24
putamen, newborn, donor10223	10365-105F5	42.73	11.24	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	29.97	9.31	1.75	0.58
rectum, fetal, donor1	10067-101I4	75.11	23.65	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	20.35	5.30	1.91	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.05	1.24	2.07	0.00
retina, adult, pool1	10030-101E3	24.45	11.63	0.99	0.30
retinoblastoma cell line:Y79	10475-106I7	69.37	25.98	3.90	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	17.70	4.92	1.72	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.81	4.50	1.12	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	3.03	0.76	0.00
salivary acinar cells, donor1	11771-123I7	12.95	6.15	0.97	0.00
salivary acinar cells, donor2	11772-123I8	17.21	9.78	0.96	0.83
salivary acinar cells, donor3	11773-123I9	8.61	3.31	1.99	0.00
salivary gland, adult, pool1	10093-102C3	25.74	9.15	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.60	9.70	0.25	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.81	8.23	0.71	0.12
seminal vesicle, adult	10201-103F3	33.33	11.11	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.01	6.07	3.16	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.75	11.07	3.52	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	39.14	12.04	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.60	2.69	1.61	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	45.65	15.14	1.88	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.32	11.48	1.03	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	51.78	14.19	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	29.98	9.71	0.60	0.96
skeletal muscle, fetal, donor1	10066-101I3	252.26	43.22	12.06	4.02
skin, adult, donor1	10074-102A2	20.36	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	83.95	20.20	4.42	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	83.38	13.01	8.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	61.78	27.74	1.89	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	41.25	7.90	3.08	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	49.94	13.85	4.62	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	36.03	7.08	1.61	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	36.61	16.34	0.87	0.00
small intestine, adult, pool1	10024-101D6	19.59	13.02	0.84	0.60
small intestine, fetal, donor1	10064-101I1	29.73	13.02	2.21	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.09	17.95	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	13.96	5.43	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	24.12	7.24	2.95	0.00
spinal cord - adult, donor10196	10181-103D1	29.82	8.49	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	21.29	14.19	1.97	1.18
spinal cord, adult, donor10258	10369-105F9	19.37	2.77	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	72.57	17.08	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	17.91	7.81	0.46	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.60	2.39	0.45	0.30
spleen, adult, pool1	10025-101D7	19.49	13.88	0.55	1.65
spleen, fetal, pool1	10044-101F8	190.85	27.97	4.37	2.07
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	10.04	6.73	0.41	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	52.03	3.80	7.22	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	3.84	4.54	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	5.47	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	59.99	12.27	1.35	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	176.64	23.72	7.62	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	51.61	7.19	3.38	0.85
stomach, fetal, donor1	10062-101H8	29.90	8.54	3.20	0.00
submaxillary gland, adult	10202-103F4	26.77	13.10	0.57	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.90	6.65	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	10.86	3.10	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	43.10	9.89	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	81.39	39.89	2.75	1.38
temporal lobe, adult, pool1	10031-101E4	17.80	6.02	0.42	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	131.06	19.94	4.99	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	79.12	13.19	2.20	0.44
tenocyte, donor1	11763-123H8	12.92	2.79	1.75	0.35
tenocyte, donor2	11765-123I1	8.77	2.67	1.91	0.00
tenocyte, donor3	11768-123I4	7.04	2.22	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	46.57	22.60	1.19	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	38.69	14.64	2.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	19.53	7.28	1.08	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.60	6.35	0.89	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	37.82	6.43	1.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.23	5.02	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	22.80	6.84	0.65	0.65
testis, adult, pool1	10026-101D8	76.56	37.69	2.58	3.22
testis, adult, pool2	10096-102C6	145.25	44.21	5.86	3.61
thalamus - adult, donor10196	10168-103B6	17.66	4.42	1.10	2.21
thalamus, adult, donor10252	10154-103A1	23.29	8.75	0.47	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.14	6.75	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	27.62	6.33	0.58	0.00
throat, adult	10209-103G2	37.20	10.74	2.00	1.25
throat, fetal, donor1	10061-101H7	75.87	17.06	3.66	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	83.47	38.36	2.19	1.59
thymus, adult, pool1	10027-101D9	43.54	29.13	2.58	1.59
thymus, fetal, pool1	10043-101F7	48.11	22.34	1.45	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.96	5.05	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	41.21	11.87	1.54	0.28
thyroid, adult, pool1	10028-101E1	28.37	8.12	1.12	0.56
thyroid, fetal, donor1	10060-101H6	44.03	11.60	1.32	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	18.48	3.08	0.00
tongue, adult	10203-103F5	16.98	9.77	1.40	0.70
tongue, fetal, donor1	10059-101H5	34.29	13.40	0.79	0.39
tonsil, adult, pool1	10047-101G2	32.86	20.04	1.90	1.40
trachea, adult, pool1	10029-101E2	21.68	10.47	1.39	0.41
trachea, fetal, donor1	10058-101H4	133.87	25.77	5.00	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.27	4.61	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	47.21	11.96	4.36	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.49	6.42	1.57	0.31
tridermal teratoma cell line:HGRT	10694-109G1	7.61	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.32	3.64	2.20	0.17
umbilical cord, fetal, donor1	10057-101H3	81.37	16.69	0.00	0.00
uterus, adult, pool1	10100-102D1	23.03	10.41	0.68	0.51
uterus, fetal, donor1	10055-101H1	83.96	24.06	5.12	1.02
vagina, adult	10204-103F6	27.14	7.11	0.65	0.65
vein, adult	10191-103E2	16.00	11.84	0.44	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.95	8.81	0.80	0.80